ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Patrick J Heron bought $69K of Arcutis Biotherapeutics, Inc.
Bought$68,821
$13.66Price
5,040Shares
What ARQT did for a copier
- $1,000 copied at Tue, May 27 open, $14.26
- $1,071
- S&P 500, same days
- +7.1%
Measured over 30 trading days, to the Jul 10 close.
Patrick J Heron's record
15 other buys with 3 months of prices since 2020: on average +6.2% against the S&P 500, and 9 of 15 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, May 21. Filed Fri, May 23, 4:04 PM ET, after the close. Returns use the May 27 open and the Jul 10 close. Not investment advice.